NCT06952660 2026-03-12Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerPfizerPhase 4 Recruiting100 enrolled
NCT03562897 2022-07-06Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial CancerCatalysis SLPhase 2 Completed40 enrolled